Loading
Bright Minds Biosciences Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Cormorant Asset Management, LP, was filed 06 Nov 2024.
Insider Decl.
143
Thresholds
n/a
Buy Volume
€10M
77 ops. · all time
Sell Volume
€17M
15 ops. · all time
Who traded when
BuySaleRyan Cheung5 buys2 sales
Nils Bottler2 buys4 sales
Cormorant Asset Management, LP1 buy1 sale
Jan Torleif Pedersen2 sales
Cormorant Asset Management LP1 sale
Ian McDonald1 buy
+1 other insider
Since the insiders bought
- +21.2%Entry US$48.52 · Close at T+365 US$58.79
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Bright Minds Biosciences Inc. Strong Buy (bullish), based on 7 analysts. Average price target: US$154.34.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended September 2025 · cache
US$50.44
Analyst consensus
7 analystsStrong buy
US$124.66Target US$154.34(+206%)US$223.61
Income statement
EBITDA-US$13.9M
Net income-US$12.2M0.0% margin
Valuation
PER (forward)-6.2x
P/Book2.3x
Beta0.23
Balance sheet & cash
Market capUS$497.5M
Total debtUS$125.8k
Free Cash Flow-US$8.7M
Debt / Equity0%
Profitability & ownership
ROE-13.6%
ROA-13.5%
% insiders11.9%
% institutions94.9%
Last declaration on 21 October 2026
Declarations143 total
35,000 shares@ CA$1.8522.3% of flowOptionsTSXSEDI:4793473
5,000 shares@ CA$1.652.8% of flowOptionsTSXSEDI:4793472
4,500 shares@ CA$5.248.1% of flowOptionsTSXSEDI:4793471
100 shares@ CA$71.000.0010% mcap20.3% of flowCommon SharesTSXSEDI:4791342
Canonical exit: 12 Jan 2027 (T+90)
100 shares@ CA$69.980.0010% mcap24.9% of flowCommon SharesTSXSEDI:4788786
Canonical exit: 4 Jan 2027 (T+90)
100 shares@ CA$70.450.0010% mcap33.2% of flowCommon SharesTSXSEDI:4786326
Canonical exit: 31 Dec 2026 (T+90)
100 shares@ CA$70.500.0010% mcap33.2% of flowCommon SharesTSXSEDI:4786325
Canonical exit: 31 Dec 2026 (T+90)
100 shares@ CA$71.520.0010% mcap100.0% of flowCommon SharesTSXSEDI:4783168
Canonical exit: 29 Dec 2026 (T+90)
109,331 shares@ CA$89.501.05% mcap100.0% of flowCommon SharesTSXSEDI:4738110
35,000 shares@ CA$1.8567.0% of flowOptionsTSXSEDI:4736415
5,000 shares@ CA$1.658.5% of flowOptionsTSXSEDI:4736414
4,500 shares@ CA$5.2424.4% of flowOptionsTSXSEDI:4736412
20,000 sharesOptionsTSXSEDI:4735545
OptionsTSXSEDI:4735541
30,000 sharesOptionsTSXSEDI:4735519
100,000 sharesOptionsTSXSEDI:4735515
OptionsTSXSEDI:4735508
1,625 shares@ CA$61.0810.010% mcap100.0% of flowCommon SharesTSXSEDI:4735012
Canonical exit: 10 Sept 2026 (T+90)
5,000 shares@ CA$1.840.0009% mcap2.0% of flowCommon SharesTSXSEDI:4733419
Canonical exit: 30 Aug 2026 (T+90)
2,500 shares@ CA$1.650.0004% mcap0.9% of flowCommon SharesTSXSEDI:4733417
Canonical exit: 30 Aug 2026 (T+90)
2,500 shares@ CA$1.650.0003% mcap0.9% of flowCommon SharesTSXSEDI:4732666
5,000 shares@ CA$1.840.0008% mcap2.0% of flowCommon SharesTSXSEDI:4732634
5,000 sharesOptionsTSXSEDI:4732631
2,500 sharesOptionsTSXSEDI:4732630
5,000 shares@ CA$85.170.036% mcap94.1% of flowCommon SharesTSXSEDI:4732622
25 of 143 declarations
About Bright Minds Biosciences Inc.
Two main lines stand out at Bright Minds Biosciences Inc., a health care company listed on Nasdaq. First Cormorant Asset Management: a purchase of EUR 3,678,304 on November 4, 2024 and EUR 991,054 on October 15, 2024, then, on April 28, 2026, two sales of EUR 8,350,625 and EUR 6,103,569. The 7 sales in the record weigh EUR 14,820,766, with a median of EUR 78,016.
Then Ian McDonald, Director of Issuer and Senior Officer of Issuer, who signs 59 of the 115 filings, 54 of them purchases, small ones: the 75 purchases with an amount are worth EUR 6,950,315 in total, with a median of EUR 3,573. The largest, EUR 849,377, dates from October 16, 2024. Nils Bottler, Director of Issuer, sold EUR 264,708 on June 1, 2026.
Read moreShow less
Volume is heavily concentrated: 66 filings in 2021, then 1 in 2023, 14 in 2024, 8 in 2025 and 26 in 2026. The record also holds 19 option exercises. Over the last twelve months: 26 filings, 8 purchases, 3 sales. Market capitalisation is USD 530.9 million. For 70 purchases a 90-day result is stored: a median of minus -14.5%, with 19% of results positive. These are recorded past results, not a forecast.
